Ad Hoc News

Sorrento Therapeutics stock reflects micro-cap status with minimal trading

Sorrento Therapeutics stock currently trades at a fraction of a cent as of September 18, 2026, underscoring its micro-cap status in the biotechnology sector. Recent data highlight the company’s very ...
ad-hoc-news

Sorrento Therapeutics Stock: From Nasdaq Delisting To Penny-Stock Limbo

Once a high?flying Covid and oncology hopeful, Sorrento Therapeutics now trades as a distressed penny stock under SRNE. With the company in Chapter 11 and its Nasdaq listing gone, the stock’s recent ...
Barron's

Sorrento Therapeutics Inc.

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento ...
Nasdaq

Sorrento Issues a "FAQ" in Response to Large Number Of Urgent Requests from Scilex Dividend Short Holders and/or Record Holders

SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, ...